Ellington Management Group’s Bausch Health BHC Stock Holding History

Ellington Management Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.76M	Buy	+60,000	New	+$1.82M	0.26%	56

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Ellington Management Group's BHC Position: Q4 2019 in Review

Ellington Management Group sold out of Bausch Health (BHC) in Q4 2019, closing a stake of 11,300 shares — an estimated $247K sold.

Ellington Management Group first reported a position in BHC in Q2 2015 and held it in 5 quarters. The position peaked at $1.12M in Q1 2017. 327 funds tracked by Wall St. Rank hold BHC as of Q4 2019.

Ellington Management Group reported no remaining Bausch Health position as of Q4 2019 after selling out during the quarter.
Ellington Management Group sold 11,300 Bausch Health shares in Q4 2019, an estimated $247K.
Ellington Management Group first reported a position in Bausch Health in Q2 2015 and held it in 5 quarters.
Ellington Management Group's Bausch Health position peaked at $1.12M in Q1 2017.
327 funds tracked by Wall St. Rank held Bausch Health as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.